IP Library Granted Patent US 7,208,106
Granted Patent B2
US 7,208,106 · App. 10/536,330 · Granted Apr 24, 2007

Method of forming particles

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,208,106
App. No.
10/536,330
Granted
Apr 24, 2007
Kind
B2
Abstract

The present invention provides a method of forming particles that involves contacting a solution, which includes a solute and/or other material to be precipitated dissolved or dispersed in a solvent, with a first compressed or liquefied gas at an initial temperature to form a mixture. The mixture is then expanded at a first temperature to form droplets. Depending upon the composition of the droplets and the first temperature, the droplets may be in a solid state or a liquid state. The droplets are then contacted with an extracting fluid at a second temperature to extract the solvent from the droplets. The method can be used to produce micro and nanoparticles suitable for various drug delivery systems.

Claims (29)

1. A method of forming particles comprising:

providing a solution comprising a solute dispersed or dissolved in a solvent;

contacting the solution with a first compressed or liquefied gas at an initial temperature to form a mixture;

expanding the mixture at a first temperature to form droplets;

contacting the droplets with an extracting fluid at a second temperature at which the solvent is extracted from the droplets to form particles comprising the solute; and

separating the particles from the extracting fluid and solvent.

2. The method according to claim 1 wherein the extracting fluid comprises a homogeneous blend of a second compressed or liquefied gas and a co-solvent.

3. The method according to claim 1 wherein the first temperature is below the freezing point of the solution thereby forming droplets that are in a solid state when the droplets contact the extracting fluid.

4. The method according to claim 1 wherein the first temperature is above the freezing point of the solution thereby forming droplets that are in a liquid state when the droplets contact the extracting fluid.

5. The method according to claim 4 wherein the droplets freeze upon contacting the extracting fluid.

6. The method according to claim 1 wherein the droplets are injected subsurface into the extracting fluid.

7. The method according to claim 1 further comprising removing the extracting fluid and solvent from the particles by contacting the same with a supercritical fluid at a third temperature.

8. The method according to claim 1 wherein the solute is a biologically active agent selected from the group consisting of proteins, monoclonal antibodies, peptides, nucleic acids, polysaccharides, steroids, antibiotics, anesthetics, sedatives, cardiovascular agents, anti-tumor agents, vitamins, organic and inorganic drugs, and diagnostic agents.

9. The method according to claim 1 wherein the solution further comprises an excipient selected from the group consisting of sugars, salts, buffers, stabilizers, surfactants, amino-acids, bulking agents, dispersion and release enhancing agents.

10. The method according to claim 1 wherein the solution further comprises a polymer selected from the group consisting of biodegradable polymers, biocompatible polymers and lipids.

11. The method according to claim 1 wherein the particles have a mean diameter within the range of from about 0.05 to 1000 μm.

12. The method according to claim 1 wherein the particles have a mean diameter within the range of from about 0.5 to 5 μm and are suitable for use in respiratory applications.

13. The method according to claim 1 wherein the particles have a mean diameter within the range of from about 0.05 to 1 μm and are suitable for use in nano-formulations.

14. The method according to claim 2 wherein the weight ratio of the second compressed or liquefied gas to the co-solvent in the extracting fluid is adjusted within the range of from about 0:100 to about 100:0, depending on the required extraction temperature and miscibility between liquefied gas and co-solvents.

15. The method according to claim 1 wherein the second compressed or liquefied gas in extracting fluid is selected from the group consisting of carbon dioxide, propane, ethane, nitrogen oxide, ammonia, and hydrofluorocarbons.

16. The method according to claim 1 wherein the first compressed or liquefied gas is selected from the group consisting carbon dioxide, propane, ethane, nitrogen oxide, ammonia, and hydrofluorocarbons.

17. The method according to claim 1 wherein the first compressed or liquefied gas is selected from the group consisting of air, nitrogen, argon and xenon.

18. The method according to claim 1 wherein the solution and the first compressed or liquefied gas are mixed together in a nozzle.

19. The method according to claim 1 wherein the solvent is selected from the group consisting of ethanol, alcohol group, acetone, pentane, isopentane, ethyl acetate, methylene chloride, chloroform, dimethyl sulfoxide (DMSO), dimethyl formamide (DMF), tetrahydrofuran (THF), water, and combinations thereof.

20. A method of forming particles comprising:

providing a solution comprising a solute dispersed or dissolved in a solvent;

injecting the solution subsurface into an extracting fluid at a rate sufficient to cause the injected solution to form droplets within the extracting fluid;

extracting the solvent from the droplets to form particles comprising the solute; and

separating the particles from the extracting fluid and solvent.

Assignments (10)
SECURITY INTEREST Recorded May 2, 2022
From: CHROMAFLO TECHNOLOGIES CORPORATION; FERRO CORPORATION; FERRO ELECTRONIC MATERIALS INC.; PRINCE ENERGY LLC; PRINCE MINERALS LLC; PRINCE SPECIALTY PRODUCTS LLC
To: CREDIT SUISSE AG, CAYMAN ISLANDS BRANCH, AS ADMINISTRATIVE AGENT
Reel/Frame 059845/0082 →
RELEASE OF SECURITY INTEREST IN PATENTS RECORDED AT R/F 041736/0178 Recorded Apr 21, 2022
From: PNC BANK NATIONAL ASSOCIATION, AS COLLATERAL AGENT
To: FERRO CORPORATION
Reel/Frame 059747/0129 →
SECURITY INTEREST Recorded Feb 16, 2017
From: FERRO CORPORATION
To: PNC BANK, NATIONAL ASSOCIATION, AS COLLATERAL AGENT
Reel/Frame 041736/0178 →
RELEASE OF SECURITY INTEREST Recorded Feb 15, 2017
From: PNC BANK, NATIONAL ASSOCIATION, AS COLLATERAL AGENT
To: FERRO CORPORATION
Reel/Frame 041718/0307 →
RELEASE OF SECURITY INTEREST IN PATENT COLLATERAL (RELEASES RF 024804/0117) Recorded Aug 12, 2014
From: PNC BANK, NATIONAL ASSOCIATION (AS SUCCESSOR-BY-MERGER TO NATIONAL CITY BANK)
To: FERRO CORPORATION
Reel/Frame 033522/0839 →
RELEASE OF SECURITY INTEREST IN PATENT COLLATERAL (RELEASES RF 024906/0728) Recorded Aug 12, 2014
From: PNC BANK, NATIONAL ASSOCIATION (AS SUCCESSOR-BY-MERGER TO NATIONAL CITY BANK)
To: FERRO CORPORATION
Reel/Frame 033522/0875 →
PATENT SECURITY AGREEMENT Recorded Aug 12, 2014
From: FERRO CORPORATION
To: PNC BANK, NATIONAL ASSOCIATION
Reel/Frame 033522/0966 →
RELEASE OF SECURITY INTEREST IN PATENT COLLATERAL (RELEASES RF 017527/0047) Recorded Aug 12, 2014
From: PNC BANK, NATIONAL ASSOCIATION (AS SUCCESSOR-BY-MERGER TO NATIONAL CITY BANK)
To: FERRO PFANSTIEHL LABORATORIES, INC.
Reel/Frame 033522/0253 →
RELEASE OF SECURITY INTEREST IN PATENT COLLATERAL (RELEASES RF 017746/0052) Recorded Aug 12, 2014
From: PNC BANK, NATIONAL ASSOCIATION (AS SUCCESSOR-BY-MERGER TO NATIONAL CITY BANK)
To: FERRO PFANSTIEHL LABORATORIES, INC.
Reel/Frame 033522/0284 →
RELEASE OF SECURITY INTEREST IN PATENT COLLATERAL (RELEASES RF 024804/0139) Recorded Aug 12, 2014
From: PNC BANK, NATIONAL ASSOCIATION (AS SUCCESSOR-BY-MERGER TO NATIONAL CITY BANK)
To: FERRO CORPORATION
Reel/Frame 033522/0755 →